Transplacental: Difference between revisions
No edit summary |
m Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +) |
||
Line 7: | Line 7: | ||
[[Category:Obstetrics]] | [[Category:Obstetrics]] | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} |
Latest revision as of 17:02, 20 August 2012
WikiDoc Resources for Transplacental |
Articles |
---|
Most recent articles on Transplacental Most cited articles on Transplacental |
Media |
Powerpoint slides on Transplacental |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Transplacental at Clinical Trials.gov Trial results on Transplacental Clinical Trials on Transplacental at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Transplacental NICE Guidance on Transplacental
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Transplacental Discussion groups on Transplacental Patient Handouts on Transplacental Directions to Hospitals Treating Transplacental Risk calculators and risk factors for Transplacental
|
Healthcare Provider Resources |
Causes & Risk Factors for Transplacental |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Transplacental refers to the ability of a toxin or pathogen to cross the physical and biological barriers of the placenta separating the mother and fetus, to whom such substances may be dangerous. This would include, for example, HIV and the drug thalidomide.